Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Yonghe Medical

Legend Biotech is a biotech

BRIEF: Yonghe Medical returns to the black in first half of 2025

Hair transplant company Yonghe Medical Group Co. Ltd. (2279.HK) on Tuesday said it returned to the black in the first half of 2025, adding it expects to report a net…
July 29, 2025
2279.HK
So-Young stock surges

So-Young rethinks reverse share split as its stock surges

The cosmetic surgery specialist’s shares have nearly doubled in the last two weeks as investors flock to its new business model centered on self-operated clinics Key Takeaways: So-Young has delayed…
June 25, 2025
SY.US
Kintor makes Koshine, a hair loss product

Kintor Pharma shifts from cancer drugs to cosmetics as funds run low

The cash-strapped biotech has begun generating its first revenue from over-the-counter cosmetic treatments, as it pivots away from its original oncology drugs Key Takeaways: Kintor Pharma is shifting from its…
May 15, 2025
9939.HK
Legend Biotech is a biotech

BRIEF: Yonghe Medical’s loss narrows on improved efficiency

Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) said on Tuesday it expects its net loss for 2024 to narrow significantly to 246 million yuan ($33.73 million) or less,…
March 4, 2025
2279.HK
The share price fell nearly 40% in a week after this drugs company was dropped from a scheme allowing mainland investors to trade Hong Kong-listed stocks.

Stock disconnect triggers investor exodus from CStone Pharma

The share price fell nearly 40% in a week after the drugs company was dropped from a scheme allowing mainland investors to trade Hong Kong-listed stocks Key Takeaways: CEO Jason…
March 14, 2024
2616.HK
Yonghe Medical launches share buyback

Yonghe Medical’s share repurchase gets results, but can’t hide a receding profit line

A big run-up in wages and marketing costs related to its aggressive expansion pulled the hair restoration company into the red in the first half of this year Key Takeaways:…
November 6, 2023
2279.HK
Hair transplant specialist Yonghe Medical expects a net loss of about 240 million yuan in the first half of the year,

FAST NEWS: Yonghe Medical swings to red, sending shares to new low

The latest: Hair transplant specialist Yonghe Medical Group Co. Ltd. (2279.HK) issued a profit warning last Friday, saying it expects a net loss of about 240 million yuan ($33.6 million) in the first half…
August 7, 2023
2279.HK
Load more

Recent Articles

Legend Biotech is a biotech
July 29, 2025

BRIEF: Yonghe Medical returns to the black in first half of 2025

2279.HK
June 25, 2025

So-Young rethinks reverse share split as its stock surges

SY.US
May 15, 2025

Kintor Pharma shifts from cancer drugs to cosmetics as funds run low

9939.HK
March 4, 2025

BRIEF: Yonghe Medical’s loss narrows on improved efficiency

2279.HK
March 14, 2024

Stock disconnect triggers investor exodus from CStone Pharma

2616.HK
November 6, 2023

Yonghe Medical’s share repurchase gets results, but can’t hide a receding profit line

2279.HK
August 7, 2023

FAST NEWS: Yonghe Medical swings to red, sending shares to new low

2279.HK

RELATED ARTICLES

  1. Legend Biotech is a biotech
    March 4, 2025
    BRIEF: Yonghe Medical’s loss narrows on improved efficiency
    2279.HK
  2. May 15, 2025
    Kintor Pharma shifts from cancer drugs to cosmetics as funds run low
    9939.HK
  3. March 21, 2025
    Baozun returns to the black as Gap expansion accelerates
    9991.HK BZUN.US
  4. February 27, 2025
    Airdoc Tech enjoys healing properties of medical AI rally
    2251.HK
  5. July 23, 2025
    BRIEF: Strawbear Entertainment swings into the red in first half of 2025
    2125.HK
  6. July 18, 2025
    BRIEF: MicroPort ‘s revenue soars in first half of 2025
    2252.HK
  7. July 15, 2025
    BRIEF: Shandong Gold profit surges in first half of 2025
    1787.HK 600547.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.